Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
2051
DELISTED
MRC Global
MRC
| $454K | ﹤0.01% |
36,090
+3
| +0% | +$34 |
|
2052
F&G Annuities & Life
FG
$3.86B
| $454K | ﹤0.01% |
11,199
-76,519
| -87% | -$3.2M |
|
2053
indie Semiconductor
INDI
$668M
| $453K | ﹤0.01% |
63,859
+106
| +0.2% | +$718 |
|
2054
First Advantage
FA
$3.44B
| $451K | ﹤0.01% |
27,831
| – | – |
|
|
LBAI
2055
DELISTED
Lakeland Bancorp Inc
LBAI
| $451K | ﹤0.01% |
37,396
+2
| +0% | +$26 |
|
2056
Globalstar
GSAT
$10.3B
| $451K | ﹤0.01% |
20,595
+9
| +0% | +$218 |
|
2057
Mativ Holdings
MATV
$472M
| $451K | ﹤0.01% |
24,068
-2
| -0% | -$30 |
|
|
VZIO
2058
DELISTED
VIZIO Holding Corp.
VZIO
| $450K | ﹤0.01% |
41,158
+6
| +0% | +$55 |
|
2059
Krispy Kreme
DNUT
$553M
| $450K | ﹤0.01% |
29,536
+10
| +0% | +$133 |
|
2060
Lemonade
LMND
$3.76B
| $445K | ﹤0.01% |
27,107
+1
| +0% | +$17 |
|
|
PGRE
2061
DELISTED
Paramount Group
PGRE
| $443K | ﹤0.01% |
94,544
+4
| +0% | +$19 |
|
2062
Chegg
CHGG
$118M
| $442K | ﹤0.01% |
58,440
-63
| -0.1% | -$577 |
|
2063
Revolve Group
RVLV
$1.82B
| $440K | ﹤0.01% |
20,791
-11,442
| -35% | -$201K |
|
2064
Protolabs
PRLB
$1.79B
| $439K | ﹤0.01% |
12,292
| – | – |
|
2065
Cytek Biosciences
CTKB
$557M
| $438K | ﹤0.01% |
65,474
+11
| +0% | +$87 |
|
2066
OceanFirst Financial
OCFC
$1.71B
| $437K | ﹤0.01% |
26,687
+1
| +0% | +$16 |
|
|
BASE
2067
DELISTED
Couchbase
BASE
| $436K | ﹤0.01% |
16,578
+12
| +0.1% | +$312 |
|
2068
Interface
TILE
$1.96B
| $432K | ﹤0.01% |
25,723
+2
| +0% | +$28 |
|
2069
Anterix
ATEX
$1.82B
| $430K | ﹤0.01% |
+12,764
| New | +$429K |
|
2070
Innoviva
INVA
$1.57B
| $429K | ﹤0.01% |
28,187
+3
| +0% | +$47 |
|
2071
Astec Industries
ASTE
$1.18B
| $429K | ﹤0.01% |
9,798
| – | – |
|
2072
Thryv Holdings
THRY
$180M
| $428K | ﹤0.01% |
19,281
+2
| +0% | +$41 |
|
2073
AMERISAFE
AMSF
$549M
| $428K | ﹤0.01% |
8,532
| – | – |
|
2074
B&G Foods
BGS
$293M
| $427K | ﹤0.01% |
37,335
+35
| +0.1% | +$367 |
|
2075
Hovnanian Enterprises
HOV
$758M
| $427K | ﹤0.01% |
2,724
| – | – |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.